Qube Research & Technologies LTD Tff Pharmaceuticals, Inc. Transaction History

Qube Research & Technologies LTD

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 13, 2023	BUY	$0.31 - $0.48 $0 - $0	1 New	1 $0
Q3 2022 Nov 14, 2022	BUY	$4.61 - $116.0 $15,480 - $389,528	3,358 Added 20.59%	19,663 $80,000
Q2 2022 Aug 15, 2022	BUY	$3.99 - $7.22 $65,056 - $117,722	16,305 New	16,305 $92,000
Q1 2021 May 14, 2021	SELL	$12.96 - $19.75 $719,824 - $1.1 Million	-55,542 Closed	0 $0
Q4 2020 Feb 16, 2021	BUY	$12.74 - $18.49 $106,621 - $154,742	8,369 Added 17.74%	55,542 $795,000
Q3 2020 Nov 12, 2020	BUY	$5.86 - $18.47 $276,433 - $871,285	47,173 New	47,173 $871,000

Ticker TFFP
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 25,477,800
Market Cap $8.66M
Description
TFF Pharmaceuticals, Inc., a clinical stage biopharmaceutical company, focuses on developing and commercializing drug products based on its patented Thin Film Freezing (TFF) technology platform in the United States and Australia. It intends to focus on the development of inhaled dry powder drugs for the treatment of pulmonary diseases and condit...

Get notified when there are updates to the investment portfolio of Qube Research & Technologies LTD, based on Form 13F filings with the SEC.

Stay updated on Qube Research & Technologies LTD with notifications on news.